The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD

References

• ChapmanKRManninoDMSorianoJBEpidemiology and costs of chronic obstructive pulmonary diseaseEur Respir J200627118820716387952
   PubMed Web of Science ®Google Scholar
• global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease2014 Available from: http://www.goldcopd.orgAccessed January 1, 2015
   Google Scholar
• AfonsoASVerhammeKMSturkenboomMCBrusselleGGCOPD in the general population: prevalence, incidence and survivalRespir Med2011105121872188421852081
   PubMed Web of Science ®Google Scholar
• MaureenPMHvan-MölkenRFeenstraTLThe burden of asthma and chronic obstructive pulmonary diseasePharmacoeconomics200119216
   Google Scholar
• BuistASMcBurnieMAVollmerWMInternational variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
   PubMed Web of Science ®Google Scholar
• ChaoJDonhamPvan RooijenNWoodJGGonzalezNCMonocyte chemoattractant protein-1 released from alveolar macrophages mediates the systemic inflammation of acute alveolar hypoxiaAm J Respir Cell Mol Biol2011451536120813992
   PubMed Web of Science ®Google Scholar
• HanifKBidHKKonwarRReinventing the ACE inhibitors: some old and new implications of ACE inhibitionHypertens Res2010331112119911001
   PubMed Web of Science ®Google Scholar
• MarshallRPThe pulmonary renin-angiotensin systemCurr Pharm Des2003971572212570789
   PubMed Web of Science ®Google Scholar
• OarheCIDangVDangMHyperoxia downregulates angiotensin-converting enzyme-2 in human fetal lung fibroblastsPediatr Res201577565666225665060
   PubMed Web of Science ®Google Scholar
• ŞahanAGYılmazATaşlıyurtTAntiinflammatory effect of telmisartan on chronic obstructive pulmonary disease: 8-isoprostane concentration in exhaled breath condensateCumhuriyet Med J2014362178183
   Google Scholar
• YoungRPHopkinsRJUpdate on the potential role of statins in chronic obstructive pulmonary disease and its co-morbiditiesExpert Rev Respir Med20137553354424138695
   PubMed Web of Science ®Google Scholar
• ChungKFAdcockIMMultifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destructionEur Respir J20083161334135618515558
   PubMed Web of Science ®Google Scholar
• HussainSAlgaemMNumanIAnti-inflammatory effects of Telmisartan and Valsartan in animal models of airways inflammationPharmacologia201454149154
   Google Scholar
• LahousseLLothDWJoosGFStatins, systemic inflammation and risk of death in COPD: the Rotterdam studyPulm Pharmacol Ther201326221221723142156
   PubMed Web of Science ®Google Scholar
• ShrikrishnaDAstinRKempPRHopkinsonNSRenin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary diseaseClin Sci2012123848749822757959
   PubMed Web of Science ®Google Scholar
• LangYDHungCLWuTYWangLFChenCMThe renin-angiotensin system mediates hyperoxia-induced collagen production in human lung fibroblastsFree Radic Biol Med2010491889520353822
   PubMed Web of Science ®Google Scholar
• PodowskiMCalviCMetzgerSAngiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in miceJ Clin Invest2012122122924022182843
   PubMed Web of Science ®Google Scholar
• KatsumataUSekizawaKUjieYSasakiHTakishimaTBradykinin-induced cough reflex markedly increases in patients with cough associated with captopril and enalaprilTohoku J Exp Med19911641031091721246
   PubMed Web of Science ®Google Scholar
• SekizawaKMatsuiTNakagawaTNakayamaKSasakiHACE inhibitors and pneumoniaLancet1998352913310699759784
   PubMed Web of Science ®Google Scholar
• RaidenSNahmodKNahmodVNonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndromeJ Pharmacol Exp Ther20023031455112235231
   PubMed Web of Science ®Google Scholar
• WangHCLinCCLauCIChangAKaoCHAngiotensin-converting enzyme inhibitors and bacterial pneumonia in patients with Parkinson diseaseMov Disord201530459359625641619
   PubMed Web of Science ®Google Scholar
• ShahSMcArthurEFaragARisk of hospitalization for community acquired pneumonia with renin-angiotensin blockade in elderly patients: a population-based studyPLoS One2014910e11016525353172
   PubMed Web of Science ®Google Scholar
• ShinoharaYOrigasaHPost-stroke pneumonia prevention by angiotensin-converting enzyme inhibitors: results of a meta-analysis of five studies in AsiansAdv Ther2012291090091222983755
   PubMed Web of Science ®Google Scholar
• MortensenEMNakashimaBCornellJPopulation-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomesClin Infect Dis201255111466147322918991
   PubMed Web of Science ®Google Scholar
• LiuCLShauWYWuCSLaiMSAngiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patientsJ Hypertens201230112223222922929610
   PubMed Web of Science ®Google Scholar
• CaldeiraDAlarcãoJVaz-CarneiroACostaJRisk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysisBMJ2012345e426022786934
   PubMed Web of Science ®Google Scholar
• LiuC-LShauW-YChangC-HWuC-SLaiM-SPneumonia risk and use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockersJ Epidemiol201323534435023912052
   PubMed Web of Science ®Google Scholar
• MortensenEMPughMJCopelandLAImpact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumoniaEur Respir J200831361161717959631
   PubMed Web of Science ®Google Scholar
• NovackVMacFadyenJMalhotraAAlmogYGlynnRJRidkerPMThe effect of rosuvastatin on incident pneumonia: results from the JUPITER trialCMAJ20121847E367E37222431901
   PubMed Web of Science ®Google Scholar
• VandermeerMLThomasARKamimotoLAssociation between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate studyJ Infect Dis20122051131922170954
   PubMed Web of Science ®Google Scholar
• Global Initiative for AsthmaGlobal Strategy for Asthma Management and Prevention2014 Available from: http://ginaasthma.orgAccessed January 1, 2015
   Google Scholar
• BouletLPBeckerABérubéDBeveridgeRErnstPCanadian asthma consensus report, 1999CMAJ199916111S1S6110906907
   PubMed Web of Science ®Google Scholar
• MortensenEMCopelandLAPughMJImpact of statins and ACE inhibitors on mortality after COPD exacerbationsRespir Res2009104519493329
   PubMed Web of Science ®Google Scholar
• YawnBPLiYTianHZhangJArconaSKahlerKHInhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysisInt J Chron Obstruct Pulm Dis20138295304
   PubMed Web of Science ®Google Scholar
• SuissaSPatenaudeVLapiFErnstPInhaled corticosteroids in COPD and the risk of serious pneumoniaThorax201368111029103624130228
   PubMed Web of Science ®Google Scholar
• SeemungalTAHurstJRWedzichaJAExacerbation rate, health status and mortality in COPD – a review of potential interventionsInt J Chron Obstruct Pulm Dis20094203223
   PubMedGoogle Scholar
• JohnsonDColeySDecrease of blood pressure by ventrolateral medullary decompression in essential hypertensionLancet19983529133106910709759785
   PubMed Web of Science ®Google Scholar
• CrisafulliEMenendezRHuertaASystemic inflammatory pattern of patients with community-acquired pneumonia with and without COPDChest201314341009101723187314
   PubMed Web of Science ®Google Scholar
• KaparianosAArgyropoulouELocal renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndromeCurr Med Chem201118233506351521756232
   PubMed Web of Science ®Google Scholar
• BenigniACassisPRemuzziGAngiotensin II revisited: new roles in inflammation, immunology and agingEMBO Mol Med20102724725720597104
   PubMed Web of Science ®Google Scholar
• RahmanIAdcockIMOxidative stress and redox regulation of lung inflammation in COPDEur Respir J200628121924216816350
   PubMed Web of Science ®Google Scholar
• WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118119023945277
   PubMed Web of Science ®Google Scholar
• SalviSSBarnesPJChronic obstructive pulmonary disease in non-smokersLancet200937473374319716966
   PubMed Web of Science ®Google Scholar
• VegterSNguyenNHVisserSTLolkjeTWPostmaMJBoersmaCCompliance, persistence, and switching patterns for ACE inhibitors and ARBsAm J Manag Care201117960961621902446
   PubMed Web of Science ®Google Scholar
• KubaKImaiYPenningerJMAngiotensin-converting enzyme 2 in lung diseasesCurr Opin Pharmacol20066327127616581295
   PubMed Web of Science ®Google Scholar
• MullerovaHChigboCHaganGWThe natural history of community-acquired pneumonia in COPD patients: a population database analysisRespir Med201210681124113322621820
   PubMed Web of Science ®Google Scholar
• MartaVOlgaLSandraMMedication adherence to specific drug classes in chronic heart failureJ Manag Care Pharm2014201010181026
   Web of Science ®Google Scholar